Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 1,147 shares at $0.36 ($413) on 2022-08-31, disclosed to the SEC on 2022-09-01.
Open-market sale of $413 AKBA by SVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2025-02-04 | $163K | — | Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |